Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy

Study Identifier:
BINFORMED
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
St. Jude Children's Research Hospital
Collaborator:
N/A
Study Contact Information:
Recruiting

Study Details

Medical Condition
  • Ignored
  • Hemophilia B
Study Drug
    Date
    Jan 2022 - Dec 2025
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: 12+ years years
    Requirements Information

    Protocol Summary

    This study is looking at how safe it is to switch from emicizumab to Mim8, in people with haemophilia A. Mim8 is a new medicine that is used to prevent bleeding episodes in people with haemophilia A. Mim8 works by replacing the function of the missing clotting factor VIII (FVIII). Mim8 will be injected under the skin using a pen-injector either once every week, once every two weeks or once every month. The participants will be trained in using the pen injector. The participants can choose themselves, in collaboration with the study doctor how often they get Mim8 in this study. When the participant will get their first Mim8 injection depends on their current treatment with emicizumab. The participants will get their first Mim8 injection at Visit 2. Participants will have between 6 and 27 Mim8 injections. The total number of injections participants will have depends on their dosing frequency. The study will last for about 6-12 months. While taking part in this study, there are some restrictions about what medicine participant can use. The study doctor will tell the participants more about this. In case the participants experience bleeds, these can be treated with additional haemostatic medicine as agreed with the study doctor. Female participants cannot take part if they are pregnant, breast-feeding or plan to get pregnant during the study period.

    Trial Locations

    Location
    Status
    Location
    St. Jude Children's Research Hospital
    Memphis, Tennessee, United States, 38105
    Status
    Recruiting
    Location
    Hospital Dos De Mayo
    Lima 15003, Peru
    Status
    Recruiting
    Location
    National Hospital of Sri Lanka
    Colombo 10, Sri Lanka, 01000
    Status
    Recruiting
    Location
    Ramathibodi Hospital
    Bangkok, Thailand, 10400
    Status
    Recruiting
    Location
    National Institute of Hematology and Blood Transfusion
    Hanoi, Vietnam
    Status
    Recruiting